发布求助
文献互助 智能选刊 最新文献

A102. COPD: THERAPY最新文献

筛选
英文 中文
Predictors of Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation in Frequently Exacerbating Patients with COPD 三联治疗与双重支气管扩张在慢性阻塞性肺病频繁加重患者中的实际疗效比较预测因素
A102. COPD: THERAPY Pub Date : 2019-05-31 DOI: 10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A2445
M. Kerkhof, J. Voorham, G. Georges, S. Vezzoli, A. Papi, C. Vogelmeier, D. Singh, L. Fabbri, J. Kocks, D. Price
{"title":"Predictors of Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation in Frequently Exacerbating Patients with COPD","authors":"M. Kerkhof, J. Voorham, G. Georges, S. Vezzoli, A. Papi, C. Vogelmeier, D. Singh, L. Fabbri, J. Kocks, D. Price","doi":"10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A2445","DOIUrl":"https://doi.org/10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A2445","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"201 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128661070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Frequency of Exacerbations Treated with Antibiotics, Steroids or Both Differs by GOLD Stage in Patients with COPD in the DYNAGITO Trial 在DYNAGITO试验中，抗生素、类固醇或两者治疗COPD患者的加重频率因GOLD期而异
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2449
K. Rabe, A. Anzueto, C. Jenkins, A. Hoz, F. Voß, J. Wedzicha, P. Calverley
{"title":"The Frequency of Exacerbations Treated with Antibiotics, Steroids or Both Differs by GOLD Stage in Patients with COPD in the DYNAGITO Trial","authors":"K. Rabe, A. Anzueto, C. Jenkins, A. Hoz, F. Voß, J. Wedzicha, P. Calverley","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2449","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2449","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125468336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare Utilization in Smokers with High COPD Assessment Test Score and Preserved Lung Function COPD评估测试得分高且肺功能保留的吸烟者的医疗保健利用
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2441
A. Guerrero, M. Formiga, P. Baghaeishiva, K. Tovar, G. Urdaneta, I. Vital, Rafael A. Calderon-Candelario, G. Holt, M. Mirsaeidi, M. Campos
{"title":"Healthcare Utilization in Smokers with High COPD Assessment Test Score and Preserved Lung Function","authors":"A. Guerrero, M. Formiga, P. Baghaeishiva, K. Tovar, G. Urdaneta, I. Vital, Rafael A. Calderon-Candelario, G. Holt, M. Mirsaeidi, M. Campos","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2441","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2441","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114501968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Emphysema Heterogeneity on Lung Function in the Setting of Endobronchial Lung Volume Reduction 支气管内肺减容情况下肺气肿异质性对肺功能的影响
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2452
A. Majid, G. Criner, A. Delage
{"title":"Impact of Emphysema Heterogeneity on Lung Function in the Setting of Endobronchial Lung Volume Reduction","authors":"A. Majid, G. Criner, A. Delage","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2452","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2452","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126787852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SABA Use Around COPD Symptom-Based Exacerbations in the London COPD Cohort 伦敦COPD队列中基于COPD症状加重的SABA使用
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2453
G. Donaldson, C. Cabrera, C. Cappelletti, M. A. D. Blas, J. Wedzicha
{"title":"SABA Use Around COPD Symptom-Based Exacerbations in the London COPD Cohort","authors":"G. Donaldson, C. Cabrera, C. Cappelletti, M. A. D. Blas, J. Wedzicha","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2453","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2453","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115948287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of Bedside Ultrasound to Determine Efficacy of Lung Volume Reduction by Endobronchial Valve Therapy 床边超声评价支气管内瓣膜治疗肺减容疗效的可行性
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2442
A. Gangemi, M. Kousha, C. Kim, J. Thomas, L.-Y.H. Criner, M. Gordon, F. Cordova, V. Kim, K. Shenoy, J. Travaline, N. Marchetti, P. Desai, G. Criner
{"title":"Feasibility of Bedside Ultrasound to Determine Efficacy of Lung Volume Reduction by Endobronchial Valve Therapy","authors":"A. Gangemi, M. Kousha, C. Kim, J. Thomas, L.-Y.H. Criner, M. Gordon, F. Cordova, V. Kim, K. Shenoy, J. Travaline, N. Marchetti, P. Desai, G. Criner","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2442","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2442","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116710291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 12-52 Week (Variable Length) Randomized Double-Blind Study of Budesonide/Formoterol Fumarate Metered Dose Inhaler (BFF MDI) Compared with Formoterol Fumarate (FF) MDI in COPD (SOPHOS) 布地奈德/富马酸福莫特罗计量吸入器(BFF MDI)与富马酸福莫特罗(FF) MDI治疗COPD (SOPHOS)的12-52周随机双盲研究
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444
N. Hanania, A. Papi, A. Anzueto, F. J. Martinez, K. Rossman, C. Cappelletti, E. A. Duncan, J. Nyberg, P. Dorinsky
{"title":"A 12-52 Week (Variable Length) Randomized Double-Blind Study of Budesonide/Formoterol Fumarate Metered Dose Inhaler (BFF MDI) Compared with Formoterol Fumarate (FF) MDI in COPD (SOPHOS)","authors":"N. Hanania, A. Papi, A. Anzueto, F. J. Martinez, K. Rossman, C. Cappelletti, E. A. Duncan, J. Nyberg, P. Dorinsky","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2444","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130932656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial 单吸入三联疗法预防慢性阻塞性肺病临床重要恶化(CID): IMPACT试验的前瞻性分析
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438
M. Han, G. Criner, M. Dransfield, D. Halpin, C. E. Jones, S. Kilbride, P. Lange, David A. Lipson, D. Lomas, F. Martinez, I. Naya, S. Pascoe, R. Wise, D. Singh
{"title":"Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial","authors":"M. Han, G. Criner, M. Dransfield, D. Halpin, C. E. Jones, S. Kilbride, P. Lange, David A. Lipson, D. Lomas, F. Martinez, I. Naya, S. Pascoe, R. Wise, D. Singh","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126078334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Age on the Efficacy of Treatment of Alpha-1 Antitrypsin Deficiency (AATD) 年龄对α -1抗胰蛋白酶缺乏(AATD)治疗效果的影响
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2436
J. Ficker, K. Chapman, A. M. Turner, R. Sandhaus, M. Wencker, O. Vit, Michael Fries, N. McElvaney
{"title":"Influence of Age on the Efficacy of Treatment of Alpha-1 Antitrypsin Deficiency (AATD)","authors":"J. Ficker, K. Chapman, A. M. Turner, R. Sandhaus, M. Wencker, O. Vit, Michael Fries, N. McElvaney","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2436","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2436","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"98 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132965981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Characteristics of Subjects with Exercise-Induced Hypoxemia That Improve Their Exercise Capacity with Oxygen Supplementation 运动性低氧血症患者的特点，通过补充氧气来提高他们的运动能力
A102. COPD: THERAPY Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2439
Y. Pérez, I. Vital, R. Calderón, M. A. Campos
{"title":"Characteristics of Subjects with Exercise-Induced Hypoxemia That Improve Their Exercise Capacity with Oxygen Supplementation","authors":"Y. Pérez, I. Vital, R. Calderón, M. A. Campos","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2439","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2439","url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131123078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信